Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. Reply

Affiliations

Comment

Scott D Solomon et al. N Engl J Med. 2020.

. 2020 Mar 19;382(12):1182-1183.

doi: 10.1056/NEJMc2000284.

No abstract available

Comment on

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
van de Bovenkamp AA, van Rossum AC, Handoko ML. van de Bovenkamp AA, et al. N Engl J Med. 2020 Mar 19;382(12):1180. doi: 10.1056/NEJMc2000284. N Engl J Med. 2020. PMID: 32187476 No abstract available.
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Gupta K, Bajaj NS. Gupta K, et al. N Engl J Med. 2020 Mar 19;382(12):1180-1181. doi: 10.1056/NEJMc2000284. N Engl J Med. 2020. PMID: 32187477 No abstract available.
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Baptista R, Moraes-Sarmento P, Fontes-Carvalho R. Baptista R, et al. N Engl J Med. 2020 Mar 19;382(12):1181. doi: 10.1056/NEJMc2000284. N Engl J Med. 2020. PMID: 32187478 No abstract available.
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Yazdani B, Lutz N, Krämer BK. Yazdani B, et al. N Engl J Med. 2020 Mar 19;382(12):1181-1182. doi: 10.1056/NEJMc2000284. N Engl J Med. 2020. PMID: 32187479 No abstract available.
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Lewis GA, Schelbert EB, Miller CA. Lewis GA, et al. N Engl J Med. 2020 Mar 19;382(12):1182. doi: 10.1056/NEJMc2000284. N Engl J Med. 2020. PMID: 32187480 No abstract available.